Cancer: No More Tests for Krebiozen

While chemists were concluding that the controversial cancer drug Krebiozen is nothing but the common body chemical, creatine, a committee of 24 medical experts was checking the histories of 504 patients who were said to have benefited from the drug. Last week the committee reported unanimously that Krebiozen is ineffective. The National Cancer Institute said there will be no government-sponsored trial of Krebiozen—the case is closed.


Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!